Molecular Landscape of LncRNAs in Prostate Cancer: A focus on pathways and therapeutic targets for intervention

S Mirzaei, MDA Paskeh, E Okina, MH Gholami… - Journal of Experimental …, 2022 - Springer
Background One of the most malignant tumors in men is prostate cancer that is still incurable
due to its heterogenous and progressive natures. Genetic and epigenetic changes play …

WNT as a driver and dependency in cancer

MJ Parsons, T Tammela, LE Dow - Cancer discovery, 2021 - AACR
The WNT signaling pathway is a critical regulator of development and adult tissue
homeostasis and becomes dysregulated in many cancer types. Although hyperactivation of …

[HTML][HTML] Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patients

B Nguyen, C Fong, A Luthra, SA Smith, RG DiNatale… - Cell, 2022 - cell.com
Metastatic progression is the main cause of death in cancer patients, whereas the
underlying genomic mechanisms driving metastasis remain largely unknown. Here, we …

Chromatin profiles classify castration-resistant prostate cancers suggesting therapeutic targets

F Tang, D Xu, S Wang, CK Wong… - Science, 2022 - science.org
In castration-resistant prostate cancer (CRPC), the loss of androgen receptor (AR)
dependence leads to clinically aggressive tumors with few therapeutic options. We used …

Multiomic analysis of lung tumors defines pathways activated in neuroendocrine transformation

A Quintanal-Villalonga, H Taniguchi, YA Zhan… - Cancer discovery, 2021 - AACR
Lineage plasticity is implicated in treatment resistance in multiple cancers. In lung
adenocarcinomas (LUAD) amenable to targeted therapy, transformation to small cell lung …

Senescence induction dictates response to chemo-and immunotherapy in preclinical models of ovarian cancer

SV Paffenholz, C Salvagno, YJ Ho… - Proceedings of the …, 2022 - National Acad Sciences
High-grade serous ovarian carcinoma (HGSOC) is a cancer with dismal prognosis due to
the limited effectiveness of existing chemo-and immunotherapies. To elucidate mechanisms …

Generation of precision preclinical cancer models using regulated in vivo base editing

A Katti, A Vega-Pérez, M Foronda, J Zimmerman… - Nature …, 2024 - nature.com
Although single-nucleotide variants (SNVs) make up the majority of cancer-associated
genetic changes and have been comprehensively catalogued, little is known about their …

A MYC and RAS co-activation signature in localized prostate cancer drives bone metastasis and castration resistance

JM Arriaga, S Panja, M Alshalalfa, J Zhao, M Zou… - Nature Cancer, 2020 - nature.com
Understanding the intricacies of lethal prostate cancer poses specific challenges due to
difficulties in accurate modeling of metastasis in vivo. Here we show that NPK EYFP mice …

Genomic control of metastasis

SA Patel, P Rodrigues, L Wesolowski… - British Journal of …, 2021 - nature.com
Metastasis remains the leading cause of cancer-associated mortality, and a detailed
understanding of the metastatic process could suggest new therapeutic avenues. However …

Condensate-Promoting ENL Mutation Drives Tumorigenesis In Vivo Through Dynamic Regulation of Histone Modifications and Gene Expression

Y Liu, Q Li, L Song, C Gong, S Tang… - Cancer …, 2024 - aacrjournals.org
Gain-of-function mutations in the histone acetylation “reader” eleven-nineteen-leukemia
(ENL), found in acute myeloid leukemia (AML) and Wilms tumor, are known to drive …